Search results
Results From The WOW.Com Content Network
Cardiology. Acute decompensated heart failure ( ADHF) is a sudden worsening of the signs and symptoms of heart failure, which typically includes difficulty breathing ( dyspnea ), leg or feet swelling, and fatigue. [ 1] ADHF is a common and potentially serious cause of acute respiratory distress. The condition is caused by severe congestion of ...
The International Classification of Diseases, Clinical Modification (ICD-9-CM) was an adaptation created by the US National Center for Health Statistics (NCHS) and used in assigning diagnostic and procedure codes associated with inpatient, outpatient, and physician office utilization in the United States. The ICD-9-CM is based on the ICD-9 but ...
Tachycardia-induced cardiomyopathy (TIC) is a disease where prolonged tachycardia (a fast heart rate) or arrhythmia (an irregular heart rhythm) causes an impairment of the myocardium (heart muscle), which can result in heart failure. [ 1][ 5] People with TIC may have symptoms associated with heart failure (e.g. shortness of breath or ankle ...
Behavior modification is a primary consideration in chronic heart failure management program, with dietary guidelines regarding fluid and salt intake. [95] Fluid restriction is important to reduce fluid retention in the body and to correct the hyponatremic status of the body. [76] The evidence of benefit of reducing salt, however, is poor as of ...
Cardiac resynchronization therapy. Cardiac resynchronisation therapy ( CRT or CRT-P) is the insertion of electrodes in the left and right ventricles of the heart, as well as on occasion the right atrium, to treat heart failure by coordinating the function of the left and right ventricles via a pacemaker, a small device inserted into the ...
An implantable cardioverter-defibrillator (ICD) or automated implantable cardioverter defibrillator (AICD) is a device implantable inside the body, able to perform defibrillation, and depending on the type, cardioversion and pacing of the heart. The ICD is the first-line treatment and prophylactic therapy for patients at risk for sudden cardiac ...
Cardiac contractility modulation. Cardiac contractility modulation is a therapy which is intended for the treatment of patients with moderate to severe heart failure ( NYHA class II–IV) with symptoms despite optimal medical therapy who can benefit from an improvement in cardiac output. The short- and long-term use of this therapy enhances the ...
Per current guidelines (e.g., the ESC guidelines from 2015 and 2021) a patient has to wait at least 40 to 90 days after the cardiac event (e.g., myocardial infarction or newly diagnosed heart failure with reduced left ventricular function) before the decision to implant an ICD should be made. [21]